BACKGROUND AND PURPOSE: Discharge status and acute re-hospitalization are used as indicators of @entity64 severity and recovery. Intravenous @entity1456 ( @entity1456 ) is one of two treatments shown to have a positive impact. @entity64 rehabilitation @entity1 are an important population who will end up integrated back into the community, institutionalized or hospitalized due to @entity64 . We sought to determine factors contributing to post rehabilitation discharge and acute re-hospitalization, in particular, the impact of @entity1456 therapy. METHODS: Retrospective analysis of census data from @entity385 @entity1 on the UTHealth @entity64 /Neurorehabilitation Services at Memorial Hermann Hospital - Texas Medical Center between Jan 2011 and Nov 2013, discharged to the Community, SNF (Skilled Nursing Facility) or AC (Acute Care). Demographics and NIHSS (National Institutes of Health @entity64 Scale) were collected. Discharge FIM (Functional Independence Measure) was the reference standard. @entity281 were a negative mediator in the multivariate regression. RESULTS: Of 346 @entity1 , 274 returned to the community, 47 to SNF, and 25 to AC. NIHSS AND @entity3479 THERAPY: Median NIHSS values were 8 in the community group, 11 in SNF and 9.5 in AC. 31.8% of @entity1 received IV @entity1456 in the community group, 23.4% in SNF and 24% in AC. There were no statistically differences in community discharge rates. COMMUNITY VS AC: One day increase in rehabilitation hospitalization correlated with 19% decreased odds of AC readmission (OR 0.81; P=0.001). One unit discharge FIM increase correlated with 13% decreased odds of AC readmission (OR 0.87; P=0.003). COMMUNITY VS SNF: One year age increase correlated with 4% increased odds of SNF admission (OR 1.04; P=0.02). CONCLUSIONS: Intense rehabilitation evidenced by FIM improvement and length of stay, impacts community discharge in mild to moderate @entity64 @entity1 . @entity1456 had no effect. This study is limited by sample size, retrospective design and undetermined psychosocial factors.

Acute Intravenous XXXX Therapy does not Impact Community Discharge after Inpatient Rehabilitation.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity64 :: ('MESH:D020521', 'Disease') :: ['late stroke complications', 'stroke', 'Stroke'] @entity1456 :: ('100128998', 'Gene') :: ['t-PA', 'tissue plasminogen activator'] @entity281 :: ('MESH:D007239', 'Disease') :: ['Genitourinary infections'] @entity3479 :: ('5327', 'Gene') :: ['T-PA'] @entity385 :: ('MESH:D002544', 'Disease') :: ['ischemic stroke']
@entity1456 :: (100128998,Gene) :: ['Tissue Plasminogen Activator']
